115 related articles for article (PubMed ID: 38684171)
1. AEBP1 upregulation contributes to cervical cancer progression by facilitating cell proliferation, migration, and invasion.
Liu S; Gu Y; Shi Y; Yu S; Li W; Lv W
J Obstet Gynaecol Res; 2024 Apr; ():. PubMed ID: 38684171
[TBL] [Abstract][Full Text] [Related]
2. AEBP1 Contributes to Breast Cancer Progression by Facilitating Cell Proliferation, Migration, Invasion, and Blocking Apoptosis.
Li J; Ruan Y; Zheng C; Pan Y; Lin B; Chen Q; Zheng Z
Discov Med; 2023 Feb; 35(174):45-56. PubMed ID: 37024441
[TBL] [Abstract][Full Text] [Related]
3. AEBP1 Promotes Glioblastoma Progression and Activates the Classical NF-
Guo K; Song L; Chang J; Cao P; Liu Q
Behav Neurol; 2020; 2020():8890452. PubMed ID: 33224311
[TBL] [Abstract][Full Text] [Related]
4. Adipocyte enhancer binding protein 1 (AEBP1) knockdown suppresses human glioma cell proliferation, invasion and induces early apoptosis.
Cheng L; Shao X; Wang Q; Jiang X; Dai Y; Chen S
Pathol Res Pract; 2020 Feb; 216(2):152790. PubMed ID: 31864713
[TBL] [Abstract][Full Text] [Related]
5. AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.
Liu M; Yu Y; Zhang Z; Chen Z; Chen B; Cheng Y; Wei Y; Li J; Shang H
Ann Transl Med; 2021 Nov; 9(22):1657. PubMed ID: 34988166
[TBL] [Abstract][Full Text] [Related]
6. Silencing of adipocyte enhancer-binding protein 1 (AEBP1) alleviates renal fibrosis in vivo and in vitro via inhibition of the β-catenin signaling pathway.
Liu N; Liu D; Cao S; Lei J
Hum Cell; 2023 May; 36(3):972-986. PubMed ID: 36738398
[TBL] [Abstract][Full Text] [Related]
7. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D
Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of adipocyte enhancer-binding protein 1 in endothelial cells promotes tumor angiogenesis in colorectal cancer.
Yorozu A; Yamamoto E; Niinuma T; Tsuyada A; Maruyama R; Kitajima H; Numata Y; Kai M; Sudo G; Kubo T; Nishidate T; Okita K; Takemasa I; Nakase H; Sugai T; Takano K; Suzuki H
Cancer Sci; 2020 May; 111(5):1631-1644. PubMed ID: 32086986
[TBL] [Abstract][Full Text] [Related]
9. LINC00511 knockdown suppresses glioma cell malignant progression through miR-15a-5p/AEBP1 axis.
Liu Z; Tao B; Li L; Liu P; Xia K; Zhong C
Brain Res Bull; 2021 Aug; 173():82-96. PubMed ID: 33992709
[TBL] [Abstract][Full Text] [Related]
10. AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients.
Liu JY; Jiang L; Liu JJ; He T; Cui YH; Qian F; Yu PW
Sci Rep; 2018 Aug; 8(1):11955. PubMed ID: 30097586
[TBL] [Abstract][Full Text] [Related]
11. Stromal adipocyte enhancer-binding protein (AEBP1) promotes mammary epithelial cell hyperplasia via proinflammatory and hedgehog signaling.
Holloway RW; Bogachev O; Bharadwaj AG; McCluskey GD; Majdalawieh AF; Zhang L; Ro HS
J Biol Chem; 2012 Nov; 287(46):39171-81. PubMed ID: 22995915
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA 214 inhibits adipocyte enhancer-binding protein 1 activity and increases the sensitivity of chemotherapy in colorectal cancer.
Li S; Li C; Fang Z
Oncol Lett; 2019 Jan; 17(1):55-62. PubMed ID: 30655737
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis in endometriosis: Immunopathology insights, transcription factors and therapeutic targets.
Geng R; Huang X; Li L; Guo X; Wang Q; Zheng Y; Guo X
Front Immunol; 2022; 13():1037504. PubMed ID: 36532015
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast-specific adipocyte enhancer binding protein 1 is a potential pathological trigger and prognostic marker for liver fibrosis independent of etiology.
Zhang W; Li YJ; Zhang N; Chen SY; Tong XF; Wang BQ; Huang T; You H; Chen W
J Dig Dis; 2023 Oct; 24(10):550-561. PubMed ID: 37776122
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis.
Zhou Q; Wang X; Zhang Y; Wang L; Chen Z
BMC Oral Health; 2022 Nov; 22(1):478. PubMed ID: 36352396
[TBL] [Abstract][Full Text] [Related]
16. AEBP1 is a Novel Oncogene: Mechanisms of Action and Signaling Pathways.
Majdalawieh AF; Massri M; Ro HS
J Oncol; 2020; 2020():8097872. PubMed ID: 32565808
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
18. Gene structure and expression of the mouse adipocyte enhancer-binding protein.
Ro HS; Kim SW; Wu D; Webber C; Nicholson TE
Gene; 2001 Dec; 280(1-2):123-33. PubMed ID: 11738825
[TBL] [Abstract][Full Text] [Related]
19. HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer.
Li Z; Wei R; Yao S; Meng F; Kong L
Heliyon; 2024 Jan; 10(2):e24664. PubMed ID: 38298716
[TBL] [Abstract][Full Text] [Related]
20. Molecular Characterization of AEBP1 at Transcriptional Level in Glioma.
Wang K; Huang R; Tong X; Wang Z; Sun S; Wu C
Biomed Res Int; 2021; 2021():5579359. PubMed ID: 34373835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
